Molecular markers of various stages of non-small-cell lung cancer

Molekulyarnaya Biologiya

Volumn 38, Issue 2, 2004, Pages 191-202

  Zborovskaya, I B ^a   Tatosyan, A G ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MINISATELLITE; MOLECULAR MARKER; PROTEIN P16INK4A;

CANCER RISK; CANCER STAGING; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 9P; FUNCTIONAL DISEASE; GENE DELETION; LUNG CANCER; LUNG NON SMALL CELL CANCER; METHYLATION; ONCOGENE; PROGNOSIS; PROMOTER REGION; REVIEW; STRUCTURAL GENE; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE; EARLY DIAGNOSIS; GENETICS; HUMAN; LUNG TUMOR; RISK FACTOR;

CARCINOMA, NON-SMALL-CELL LUNG; EARLY DIAGNOSIS; HUMANS; LUNG NEOPLASMS; RISK FACTORS;

EID: 3242880109     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Capon D.J., Chen E.Y., Levinson A.D., Seeburg P.H., Geoddel D.V. 1983. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature. 302, 33-37.
2. Krontiris T.G., Di Martino N.A., Colb M., Parkinson D.R. 1985. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumor DNAs of cancer patients. Nature. 313, 369-374.
3. Krontiris T.G., Devline B., Karp D.D., Robert N.G., Risch N. 1993. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N. Engl. J. Med. 329, 517-523.
4. Rosell R., Calvo R., Sanchez J., Maurel J., Guilot M., Monzo M., Nunez L., Barnadas A. 1999. Genetic susceptibility associated with rare Hras 1 variable number of tandem repeats alleles in spanish non-small cell lung cancer patients. Clin. Cancer Res. 5, 1849-1854.
5. Lindstedt B.-A., Ryberg D., Zienolddiny S., Khan H., Haugen A. 1999. Hras 1 alleles as susceptibility markers for lung cancer: relationship to microsatellite instability in tumors. Anticancer Res. 19, 5523-5528.
6. Hirvonen A., Saarokoski S., Linnainmaa K., Koskinen K., Husgafvel-Pursiainen K., Mattson K., Vainio H. 1996. Glutatione S-transferasa and N-acetyltransferase genotypes and asbestos-associated pulmonary disoders. J. Natl. Cancer Inst. 88, 1853-1856.
7. Ryberg D., Skaug V., Hewer A., Philips D., Harries L., Wolf C., Ogreid D., Ulvik A., Vu P., Haugen A. 1996. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adducts levels and cancer risk. Carcinogenesis. 18, 1853-1856.
8. Trepicchio W.L., Krontiris T.G. 1992. Members of the rel/NF-κB famili of transcriptional regulatory proteins bind the Hras1 minisatellite DNA sequence. Nucleic Acids Res. 20, 2427-2434.
9. Mukhopadnhyay T., Roth J., Maxwell S.A. 1995. Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma. Oncogene. 11, 999-1003.
10. Green M., Krontiris T.G. 1993. Allelic variation of reporter gene activation by the Hras1 minisatellite. Genomics. 17, 429-434.
11. Lindstedt B.A., Ryberg D., Haugen A. 1997. Rare alleles at different VNTR loci among lung-cancer patients with microsatellite instability in tumors. Int. J. Cancer. 70, 412-415.
12. Hirsch F.R., Franklin W.A., Gazdar A.F., Bunn P.A. 2001. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res. 7, 5-22.
13. Wistuba I.I., Gazdar A.F., Minna J.D. 2001. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28, 3-13.
14. Chizhikov V., Chikina S., Gasparian A., Zborovskaya I., Steshina E., Ungiadze G., Samsonova M., Chernyaev A., Chuchalin A., Tatosyan A. 2002. Molecular follow up of preneoplastic lesions in bronchial epithelium of former Chernobyl cleanup workers. Oncogene. 21, 2398-2405.
15. Auerbach O., Stout A.P., Hammond F.C., Garfinkel L. 1961. Changes in bronchial epithelium in relation to smoking and cancer of the lung. New Engl. J. Med. 265, 253-267.
16. Lam S., le Riche J.C., Zheng Y., Coldman A., MacAulay C., Hawk E., Kelloff G., Gazdar A.F. 1999. Sex-related differences in bronchial epithelial changes associated with tobacco smoking. J. Natl. Cancer Inst. 91, 691-696.
17. Yakubovskaya M., Spiegelman V., Luo F.-C., Malaev S., Salnev A., Zborovskaya I., Gasparian A., Polotsky B., Machaladze Z., Trachtenberg A., Belitsky G., Ronai Z. 1995. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer. 63, 804-809.
18. Zborovskaya I., Gasparian A., Kitaeva M., Polotsky B., Tupitzin N., Machaladze Z., Gerasimov S., Shtutman M., Yakubovskaya M., Davidov M., Tatosyan A. 1996. Simultaneous detection of genetic and immunological markers in NSCLC: prediction of metastatic potential of tumor. Clin. Experim. Metastasis. 14, 490-500.
19. Heighvvay J., Tatcher N., Cemy T., Hasleton P.S. 1986. Genetic predisposition to human lung cancer. Br. J. Cancer. 53, 453-457.
20. Weston A., Caporaso N.E., Perrin L.S., Sugimura H., Tamai S., Krontiris T.G., Trump B.F., Hoover R.N., Harris C.C. 1992. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis. Environ. Health Perspect. 98, 61-67.
21. Kawashima K., Shikama H., Imoto K., Izawa M., Naruke T., Okabayashi K., Nishimura S. 1988. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs. Proc. Natl. Acad. Sci. USA. 85, 2353-2356.
22. Kawashima K., Nomura S., Hirai H., Fukushi S., Karube T., Takeuchi K., Naruke T., Nishimura S. 1992. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients. Int. J. Cancer. 50, 557-561.
23. Shih C., Kuo Y., Wang Y., Gubett L., Pozzi E. 2002. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases. Lung Cancer. 36, 125-132.
24. Tefre T., Borresen A.L., Aamdal S., Brogger A. 1990. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients. Br. J. Cancer. 61, 809-812.
25. Tamai S., Sugimura H., Caporaso N.E., Resau J.H., Trump B.F., Weston A., Harris C.C. 1990. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer. Int. J. Cancer. 46, 411-415.
26. Vineis P., Caporaso N. 1991. The analysis of restriction fragment length polymorphism in human cancer: a review from an epidemiological perspective. Int. J. Cancer. 47, 26-30.
27. Zborovskaya I., Gasparian A., Karseladze A., Elcheva I., Trofimova E., Driouch K., Trassard M., Tatosyan A., Lidereau R. 1999. Somatic genetic alterations (loh) in benign, borderline and invasive ovarian tumours: intratumoral molecular heterogeneity. Int. J. Cancer. 82, 822-826.
28. Tsuchya E., Nakamura Y., Weng S., Nakamura Y., Tsuchya S., Sugano H., Kitagawa T. 1992. Allelotype of non-small cell lung carcinoma - comparison between loss of heterozyhosity in squamos cell carcinoma and adenocarcinoma. Cancer Res. 52, 2478-2481.
29. Sato S., Nakamura Y., Tsuchya E. 1994. Difference of allelotype between squamos cell lung carcinoma and adenocarcinoma of the lungs. Cancer Res. 54, 5652-5655.
30. Fong K.M., Kida Y., Zimmerman P.V., Smith P.J. 1996. MYCL genotypes and loss of heterozyhosity in non-small cell lung cancer. Br. J. Cancer. 74, 1975-1978.
31. Gasparian A.V., Laktionov K.K., Belialova M.S.-O., Pirogova N.A., Zborovskaya I.E., Tatosyan A.G. 1998. Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small cell lung cancer. Br. J. Cancer. 77, 1604-1611.
32. Chizhikov V.V., Gasparian A.V., Zborovskaya I.B., Tatosyan A.G. 2000. Deleted regions within chromosome 1p32-pter in human non-small-cell lung cancer. Ann. Acad. Studen. 3, 26-31.
33. Chizhikov V., Zborovskaya I., Laktionov K., Delektorskaya V., Tatosyan A., Gasparian A. 2001. Two consistently deleted regions within chromosome 1p32-pter in human non-small-cell lung cancer. Mol. Carcinogenesis. 30, 151-158.
34. Nomoto S., Haruki N., Tatematsu Y., Konishi H., Mitsudomi T., Takahashi T., Takahashi T. 2000. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer. 28, 342-346.
35. Perri P., Praml C., Savelyeva L., Pillmann A., Schwab M. 1999. Fine mapping of distal 1p loci reveals TP73 at D1S468. Cytogenet. Cell Genet. 84, 111-114.
36. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Lelias J.M. 1997. Monoallellically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90, 808-819.
37. Jost C.A., Marin M.C., Kaelin W.G. 1997. p73 is a human p53-related protein that can induce apoptosis. Nature. 389, 191-194.
38. Nomoto S., Haruki N., Kondo M., Konishi H., Takahashi T., Takahashi T., Takahashi T. 1998. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 58, 1380-1383.
39. Mai M., Yokomizo A., Qian C., Yang P., Tindall D.J., Smith D.J., Liu W. 1998b. Activation of p73 silent allele in lung cancer. Cancer Res. 58, 2347-2349.
40. Mai M., Qian C., Yokomizo A., Tindall D.J., Bostwick D., Polychronakos C., Liu W. 1998a. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene. 17, 1739-1741.
41. Sunahara M., Ichimia S., Nimura Y., Takada N., Sato Y., Todo S., Nakagawara A. 1998. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int. J. Oncol. 13, 319-323.
42. Yokomizo A., Mai M., Tindall D.J., Cheng L., Bostwick D., Naito S., Smith D., Liu W. 1999. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene. 18, 1629-1633.
43. src in human small cell and non-small cell lung carcinomas. Eur. J. Cancer. 28, 372-377.
44. Little C., Nau M., Carney D., Gazdar A., Minna J. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cells. Nature. 306, 194-196.
45. Zborovskaya I., Spitkovski D., Kisseljov F. 1988. C-myc as a possible prognostic factor in some forms of human cancer. Cancer J. 2, 134-138.
46. Schmid G., Wang Z.Q., Wesierska-Gadek J. 1999. Compensatory expression of p73 in PARP-deficient mouse fibroblasts as response to a reduced level of regularly spliced wild-type p53 protein. Biochem. Biophys. Res. Commun. 255, 399-405.
47. De Laurenzi V., Costanzo A., Barcaroli D., Terrinoni A., Falco M., Annicchiaro-Petruzzelli M., Levrero M., Melino G. 1998. Two new splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 188, 1763-1768.